Deborah Ramsdell
Director · PDS Biotechnology Corp
- 2026
- Oct 21, 2026
- 1
Summary
Latest filing:
Deborah Ramsdell is Director of PDS Biotechnology Corp (PDSB). 1 SEC Form 4 filing on record, dated 21 October 2026.
Trading pattern
InsiderAlpha's records for Deborah Ramsdell go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same sector
No other insider has filed at Deborah Ramsdell's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Mario Schlosser - $62.90M in OSCR purchases and sales in the last 12 months
- BROADWOOD PARTNERS, L.P. - $62.75M in STAA purchases and sales in the last 12 months
- Jonathan M. Rothberg - $62.19M in BFLY purchases and sales in the last 12 months
- Jeffrey M. Leiden - $60.94M in VRTX purchases and sales in the last 12 months
- Dinesh V. Ph D. Patel - $60.58M in PTGX purchases and sales in the last 12 months
- David Cordani - $59.11M in CI purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Deborah Ramsdell?
Deborah Ramsdell is a corporate insider, tracked as Director of PDS Biotechnology Corp (PDSB). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Deborah Ramsdell submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.